Results 71 to 80 of about 629 (164)

Discovery and Preliminary Structure–Activity Relationship of Arylpiperazines as Novel, Brain-Penetrant Antiprion Compounds

open access: yes, 2016
Creutzfeldt-Jakob disease and kuru in humans, BSE in cattle, and scrapie in sheep are fatal neurodegenerative disorders. Such illnesses are caused by the conversion and accumulation of a misfolded pathogenic isoform (termed PrPSc) of a normally benign ...
Stanley B. Prusiner (190817)   +5 more
core   +1 more source

Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers. [PDF]

open access: yesJ Enzyme Inhib Med Chem, 2021
Wang C   +11 more
europepmc   +1 more source

4-[ω-[4-Arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine Derivatives:  Fluorescent High-Affinity Dopamine D3 Receptor Ligands as Potential Probes for Receptor Visualization

open access: yes, 2007
Sixteen long-chain arylpiperazines bearing the fluorescent moiety 2-phenylimidazo[1,2-a]pyridine were synthesized as fluorescent dopamine D3 receptors ligands (385 nM Ki 3 compounds 15a and 19a (Ki = 1.6 and 0.72 nM, respectively) showed good Stokes ...
Enza Lacivita (548487)   +6 more
core   +1 more source

Influence of cellular lipid content on influenza A virus replication. [PDF]

open access: yesArch Virol, 2020
Limsuwat N   +4 more
europepmc   +1 more source

Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis. [PDF]

open access: yesFront Oncol, 2021
Hipólito A   +4 more
europepmc   +1 more source

Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter(SERT)and 5-HT1A receptors

open access: yes, 2005
A new generation of antidepressant agents could be represented by compounds with mixed activity as serotonin transporter (SERT) inhibitors and 5-HT(1A) receptor antagonists.
COLABUFO, Nicola Antonio   +6 more
core  

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents. [PDF]

open access: yesFront Chem, 2023
Wang C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy